GlaxoSmithKline had no shortage of critics back in 2014 when it signed the deal to offload its oncology assets and take on Novartis’ vaccines business. But the…

HHS Secretary Sylvia Burwell has signed off on an $81 million fund allocation for federal agencies to continue research, though officials are stressing the…

On the heels of a $42 million supply contract with the U.S. Department of Defense, France’s Valneva has netted another big funding source. Through a loan with…

Even as some of the world’s largest drugmakers ante up in the Zika vaccine hunt, some smaller biotechs are looking to play their part in the search for a…

Building on previous vaccine collaborations in anthrax and pandemic flu, Gaithersburg, MD-based Emergent BioSolutions is moving its BARDA dealings into the…

Mayo Clinic is giving TapImmune the right to develop and commercialize its HER2/neu technology in any cancer where the HER2/neu antigen is overexpressed.

Coinciding with World Health Assembly discussions on vaccine strategy, The International Vaccine Access Center has released a data visualization platform--VIEW…

Bavarian Nordic announced today positive topline results from a Phase I trial of its RSV candidate and revealed a $100 million contract to supply HHS’ BARDA…

Deals